comparemela.com

Latest Breaking News On - Avidity partners management - Page 12 : comparemela.com

Stifel Nicolaus Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $130 00

Stifel Nicolaus Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $130 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Foster & Motley Inc Has $9 22 Million Stock Holdings in HCA Healthcare, Inc (NYSE:HCA)

Foster & Motley Inc Has $9 22 Million Stock Holdings in HCA Healthcare, Inc (NYSE:HCA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $91 00

Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its price target increased by Bank of America from $82.00 to $91.00 in a report published on Wednesday, Benzinga reports. Bank of America currently has a buy rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued research reports about the stock. Robert W. Baird […]

William Blair Weighs in on Neurogene Inc s Q1 2024 Earnings (NASDAQ:NGNE)

William Blair Weighs in on Neurogene Inc s Q1 2024 Earnings (NASDAQ:NGNE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Short Interest Update

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 5,010,000 shares, an increase of 5.7% from the February 29th total of 4,740,000 shares. Based on an average daily volume of 745,500 shares, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.